EP2907504
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.2.2012EP published:
28.6.2017EP application number:
15158288.9
EPO information:
European Patent Register
Max expiry date:
7.2.2032
Title:
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
Timeline
Today
8.2.2012EP application
28.6.2017EP Publication
Owner
Name:
Halozyme, Inc.Address:
11388 Sorrento Valley Road, 92121, San Diego, CA, US
Inventor
Name:
Xiaoming, LiAddress:
San Diego, CA California, US
Name:
Ramprasad, MysoreAddress:
San Diego, CA California, US
Name:
Thompson, CurtisAddress:
Encinitas, CA California, US
Name:
Shepard, Harold MichaelAddress:
San Diego, CA California, US
Name:
Bookbinder, Louis HowardAddress:
San Diego, CA California, US
Name:
Frost, Gregory IanAddress:
Del Mar, CA California, US
Priority
Number:
201161462875 PDate:
8.2.2011Country:
US
Classification
Categories:
A61K 9/127, A61K 38/00, A61K 38/47, A61K 47/24, A61K 9/00